View in EDS HTML Full Text PDF Full Text

A dose‐adjusted, open‐label, pilot study of the safety, tolerability, and pharmacokinetics of STC3141 in critically ill patients with sepsis.

Saved in:
Bibliographic Details
Title: A dose‐adjusted, open‐label, pilot study of the safety, tolerability, and pharmacokinetics of STC3141 in critically ill patients with sepsis.
Authors: Bellomo, Rinaldo1 (AUTHOR), Patava, John2 (AUTHOR) jpatava@innovpharma.com.au, Van Lancker, Ruth3 (AUTHOR), Layios, Nathalie4 (AUTHOR), Peetermans, Marijke5 (AUTHOR), Plummer, Mark6 (AUTHOR), Attou, Rachid7 (AUTHOR), McNamara, Robert8 (AUTHOR), Udy, Andrew9,10 (AUTHOR), Wibrow, Bradley11 (AUTHOR), Deane, Adam12 (AUTHOR), Litton, Edward13 (AUTHOR), Tanudji, Marcel2 (AUTHOR), Su, Fuhong2 (AUTHOR), Zhong, Zhang2 (AUTHOR), Shi, Linda2 (AUTHOR), Ning, Li2 (AUTHOR)
Source: Pharmacology Research & Perspectives. Oct2024, Vol. 12 Issue 5, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20521707
DOI:10.1002/prp2.70015